- Facing pharmacy trends for the remainder of the year
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Intel survey: Patients ready to embrace personalized medicine
- Bitcoin gains popularity among retailers
- Counterfeit drugs, digital technology emerge as major issues influencing health care in 2014
INDIANAPOLIS — Healthcare giant WellPoint has inked a deal with IBM whereby it will develop applications using IBM's Watson artificial intelligence technology to deliver healthcare information to patients.
Watson, named for IBM founder Thomas Watson, is a system developed by IBM scientists designed to mimic a human's ability to answer questions posed in natural language that earlier this year appeared on the TV game show "Jeopardy!" and won against two human contestants.
The companies said that Watson's ability to analyze the meaning and context of human language and process large amounts of information would assist physicians and nurses in identifying the most likely diagnosis and treatment options for their patients.